Clinical Trials on Steroid Refractory GVHD in New Zealand
Total 628 results
-
Columbia UniversityIncyte CorporationTerminatedGraft Vs Host Disease | Steroid Refractory GVHDUnited States
-
Weill Medical College of Cornell UniversityTerminatedGlucocorticosteroid Refractory Acute GVHDUnited States
-
EquilliumBiocon LimitedRecruitingGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Korea, Republic of, Israel, Spain, Germany, Belgium, Italy, Australia, France, Canada, Portugal
-
EquilliumBiocon LimitedRecruitingGVHD | GVHD, Acute | aGVHD | Acute-graft-versus-host DiseaseUnited States
-
Hackensack Meridian HealthTerminated
-
Patel, Rita Vikram, M.D.Ranbaxy Inc.CompletedAcute Steroid Responsive Dermatoses | Chronic Steroid Responsive DermatosesUnited States
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Therakos, Inc., a Mallinckrodt CompanyTerminatedSteroid Refractory Acute Graft Versus Host DiseaseUnited States, Spain, France, Austria, Germany, Hungary, Italy, United Kingdom
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Steroid-Refractory PneumonitisUnited States
-
NYU Langone HealthCompleted
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedAcute GVHDUnited States
-
Mesoblast, Inc.Quintiles, Inc.CompletedGrade B aGVHD | Grade C aGVHD | Grade D aGVHDUnited States
-
University of RochesterRecruitingBatten Disease | Neuronal Ceroid Lipofuscinosis | Neuronal Ceroid Lipofuscinosis CLN6 | Neuronal Ceroid Lipofuscinosis CLN3 | Neuronal Ceroid Lipofuscinosis CLN5 | Neuronal Ceroid Lipofuscinosis CLN1 | Neuronal Ceroid Lipofuscinosis CLN2 | Neuronal Ceroid Lipofuscinosis CLN7 | Neuronal Ceroid Lipofuscinosis... and other conditionsUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingGraft-Versus-Host Disease | GVHD | UndefinedUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Weill Medical College of Cornell UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsCompletedBatten Disease | Late Infantile Neuronal Ceroid LipofuscinosisUnited States
-
Weill Medical College of Cornell UniversityTerminatedBatten Disease | Late Infantile Neuronal Ceroid LipofuscinosisUnited States
-
Weill Medical College of Cornell UniversityNathan's Battle FoundationCompletedBatten Disease | Late Infantile Neuronal Ceroid LipofuscinosisUnited States
-
Weill Medical College of Cornell UniversityNational Institutes of Health (NIH)CompletedBatten Disease | Late-Infantile Neuronal Ceroid LipofuscinosisUnited States
-
Weill Medical College of Cornell UniversityCompletedBatten Disease | Late Infantile Neuronal Ceroid LipofuscinosisUnited States
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Cancer | Refractory CancerUnited States
-
Amicus TherapeuticsTerminatedBatten Disease | Neuronal Ceroid Lipofuscinosis CLN6 | Neuronal Ceroid Lipofuscinosis CLN3United States
-
Madeline FieldsRecruitingDrug Resistant Epilepsy | Refractory Epilepsy | Medically Refractory EpilepsyUnited States
-
NYU Langone HealthCompletedOpioid Use | Rhinoplasty | Non-steroidal Ant Inflammatory DrugsUnited States
-
CSL BehringNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruitingGraft Versus Host Disease (GVHD)United States
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompleted
-
University of RochesterBatten Disease Support and Research Assocation (BDSRA)CompletedJuvenile Neuronal Ceroid LipofuscinosisUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
PharmaMarTerminatedRelapsed/Refractory LeukemiaUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
Neurogene Inc.RecruitingNeuronal Ceroid Lipofuscinosis CLN5United States, United Kingdom
-
Roswell Park Cancer InstituteCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Alkylating Agent-Related Acute Myeloid Leukemia | Refractory Anemia With Excess Blasts in TransformationUnited States
-
Neurogene Inc.RecruitingCeroid Lipofuscinosis, Neuronal 5United States
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Eli Lilly and CompanyCompletedCancer | Refractory Solid TumorUnited States
-
Skyline Diagnostics BVIllumina, Inc.TerminatedAcute Myeloid Leukemia (AML) | Acute Promyelocytic Leukemia (APL) | Refractory Anemia With Excess of Blasts (RAEB)United States, Germany, Netherlands, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRelapsed or Refractory Solid TumorsUnited States, Argentina, Australia, Belgium, Croatia, Czechia, France, Guatemala, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Peru, Russian Federation, Serbia, South Africa, Spain, Sweden, Turkey
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada
-
John LevineCompletedGVHD | Low Risk Acute Graft-versus-host Disease | Graft-versus-host-diseaseUnited States
-
OncoMed Pharmaceuticals, Inc.CompletedRelapsed or Refractory Lymphoid MalignanciesUnited States
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
HotSpot Therapeutics, IncRecruitingSolid Tumor, Adult | Relapsed Cancer | Refractory CancerUnited States
-
Binacea Pharma, Inc.RecruitingRefractory Solid TumorsAustralia
-
All India Institute of Medical Sciences, New DelhiCouncil of Scientific and Industrial Research, IndiaCompleted
-
Roswell Park Cancer InstituteNot yet recruitingRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Mantle Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma | Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell... and other conditionsUnited States
-
Prelude TherapeuticsCompletedAdenoid Cystic Carcinoma | Refractory Chronic Myelomonocytic Leukemia | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory Diffuse Large B-cell Lymphoma | Relapsed/Refractory Advanced Solid Tumors | Relapsed/Refractory Myelodysplasia | Relapsed...United States